“…Notably, EaCpG treatment increased the expressions of some interferon response genes such as Irf7, Oas2, Oas3, SIfn2, SIfn4, and SIfn8 (Figure F) compared to pCpG treatment. Ly6c2 (lymphocyte antigen 6 complex, locus2) and Cxcl10, the indicatives of immunotherapy response, were upregulated in EaCpG compared to pCpG. − EaCpG + radiotherapy treatment increased Fcrl5, Evi2b, Cd300e, Camk1d, Aif1, Bcl11b, and Traf3ip3 compared to pCpG + radiotherapy (Figure G), which are typically associated with innate immune activation, positive regulation of NK cell and neutrophil differentiation, and macrophage and T-lymphocyte activation. − And Mt2 was downregulated in the EaCpG + radiotherapy treatment, indicating that EaCpG + radiotherapy treatment inhibited tumor cell migration . Also, both EaCpG and the combination of radiotherapy + EaCpG increased the expression of Tnf, Tlr9, and Tlr1 compared to other treatments (Figure S17).…”